Andrew Oxtoby - Net Worth and Insider Trading
Andrew Oxtoby Net Worth
The estimated net worth of Andrew Oxtoby is at least $862,767 dollars as of 2024-11-05. Andrew Oxtoby is the Chief Commercial Officer of Aimmune Therapeutics Inc and owns about 25,015 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $862,767. Details can be seen in Andrew Oxtoby's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Oxtoby has not made any transactions after 2020-03-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew Oxtoby
Andrew Oxtoby Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Oxtoby owns 2 companies in total, including Aimmune Therapeutics Inc (AIMT) , and Chinook Therapeutics Inc (KDNY) .
Click here to see the complete history of Andrew Oxtoby’s form 4 insider trades.
Insider Ownership Summary of Andrew Oxtoby
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AIMT | Aimmune Therapeutics Inc | 2020-10-10 | Chief Commercial Officer |
| KDNY | Chinook Therapeutics Inc | 2023-02-15 | Chief Commercial Officer |
Andrew Oxtoby Latest Holdings Summary
Andrew Oxtoby currently owns a total of 1 stock. Andrew Oxtoby owns 25,015 shares of Aimmune Therapeutics Inc (AIMT) as of March 13, 2020, with a value of $862,767.
Latest Holdings of Andrew Oxtoby
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AIMT | Aimmune Therapeutics Inc | 2020-03-13 | 25,015 | 34.49 | 862,767 |
Holding Weightings of Andrew Oxtoby
Andrew Oxtoby Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Oxtoby has made a total of 1 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aimmune Therapeutics Inc is the acquisition of 3,000 shares on March 13, 2020, which cost Andrew Oxtoby around $44,280.
Insider Trading History of Andrew Oxtoby
- 1
Andrew Oxtoby Trading Performance
GuruFocus tracks the stock performance after each of Andrew Oxtoby's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew Oxtoby is 19.36%. GuruFocus also compares Andrew Oxtoby's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew Oxtoby within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew Oxtoby's insider trading performs compared to the benchmark.
Performance of Andrew Oxtoby
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.08 |  | | | | |
| Relative Return to S&P 500(%) | 5.21 | | | | | |
Andrew Oxtoby Ownership Network
Ownership Network List of Andrew Oxtoby
Ownership Network Relation of Andrew Oxtoby
Andrew Oxtoby Owned Company Details
What does Aimmune Therapeutics Inc do?
Who are the key executives at Aimmune Therapeutics Inc?
Andrew Oxtoby is the Chief Commercial Officer of Aimmune Therapeutics Inc. Other key executives at Aimmune Therapeutics Inc include 10 percent owner Societe Des Produits Nestle S.a. , Chief Financial Officer Eric Bjerkholt , and Chief Medical Officer Adelman Daniel C Md .
Aimmune Therapeutics Inc (AIMT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aimmune Therapeutics Inc (AIMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aimmune Therapeutics Inc (AIMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aimmune Therapeutics Inc (AIMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aimmune Therapeutics Inc Insider Transactions
Andrew Oxtoby Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Oxtoby. You might contact Andrew Oxtoby via mailing address: 8000 Marina Boulevard, Suite 300, Brisbane Ca 94005.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
